Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00213720
Status:
TERMINATED
Last Update Posted:
2020-09-29
First Post:
2005-09-13
Brief Title:
Treatment of Subclinical Hyperthyroidism
Sponsor:
University Hospital Strasbourg France
Organization:
University Hospital Strasbourg France
Study Overview
Official Title:
Place de lIode RadioActif Dans lHyperThyroïdiE Sub-clinique PIRHATES Evaluation of the Interest of Subclinical Hyperthyroidism Treatment
Status:
TERMINATED
Status Verified Date:
2019-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
recruitment difficulties
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Objective To determine if the treatment of subclinical hyperthyroidism will reduce the rate of atrial fibrillation the main complication of this condition
Detailed Description:
Randomized open-labelled multicentre study comparing radioiodine vs medical supervision without treatment
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None